Unknown PHASE3 INTERVENTIONAL NCT00003558

Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin

A Randomized Phase III Trial of Paclitaxel, Carboplatin and Etoposide Vs. 5-Fluorouracil and Folinic Acid in the Treatment of Patients With Adenocarcinoma of Unknown Primary Site

Sponsor: Academisch Ziekenhuis Maastricht

Conditions Carcinoma of Unknown Primary

Interventions carboplatin etoposide fluorouracil leucovorin calcium paclitaxel

Updated 5 times since 2017 Last updated: Aug 6, 2013 Started: Aug 31, 1998

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Carcinoma of Unknown Primary and is currently ongoing. Academisch Ziekenhuis Maastricht leads this study, which shows 5 recorded versions since 1998 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Aug 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Academisch Ziekenhuis Maastricht

Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Maastricht, Netherlands
• Tilburg, Netherlands